Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul 16:12:691738.
doi: 10.3389/fphys.2021.691738. eCollection 2021.

The Role of Epigenetic Changes in the Progression of Alcoholic Steatohepatitis

Affiliations
Review

The Role of Epigenetic Changes in the Progression of Alcoholic Steatohepatitis

Hyeong Geug Kim et al. Front Physiol. .

Abstract

Alcoholic steatohepatitis (ASH) is a progression hepatitis with severe fatty liver and its mortality rate for 30-days in patients are over 30%. Additionally, ASH is well known for one-fifth all alcoholic related liver diseases in the world. Excessive chronic alcohol consumption is one of the most common causes of the progression of ASH and is associated with poor prognosis and liver failure. Alcohol abuse dysregulates the lipid homeostasis and causes oxidative stress and inflammation in the liver. Consequently, metabolic pathways stimulating hepatic accumulation of excessive lipid droplets are induced. Recently, many studies have indicated a link between ASH and epigenetic changes, showing differential expression of alcohol-induced epigenetic genes in the liver. However, the specific mechanisms underlying the pathogenesis of ASH remain elusive. Thus, we here summarize the current knowledge about the roles of epigenetics in lipogenesis, inflammation, and apoptosis in the context of ASH pathophysiology. Especially, we highlight the latest findings on the roles of Sirtuins, a conserved family of class-III histone deacetylases, in ASH. Additionally, we discuss the involvement of DNA methylation, histone modifications, and miRNAs in ASH as well as the ongoing efforts for the clinical translation of the findings in ASH-related epigenetic changes.

Keywords: DNA methylation; alcoholic steatohepatitis; epigenetics; miRNAs; sirtuins.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Specific roles of Sirtuins and DNA methylation in ASH. (A) Numerous SIRT-modulated mechanisms mainly regulate hepatic inflammation via inactivation of Kupffer cells and reduce lipogenesis during ASH. Sirt6 shows protective effects by normalizing the ethanol metabolism and increasing antioxidant components via enhancement of MTF1 acylation in the nucleus. Sirt3 enhances the mitochondrial apoptotic signals and prevents autophagy. (B) The role of DNA methylation in ASH. Lipid-droplet accumulation in the liver during ASH is suppressed by regulating factors associated with the lipid homeostasis or extracellular matrix via the Ufmylation pathways in hepatocytes and myofibroblasts. In plasma DNA, DNA methylation also regulates PDGFα expression during ASH.
FIGURE 2
FIGURE 2
Overview of the epigenetic changes in ASH. Metabolic pathways regulated by acetaldehyde, cytokine, and FFA are induced by excessive alcohol drinking and chronic over- nutrition. Excessive alcohol drinking and chronic over-nutrition synergistically induces ASH progression via activating several different signaling pathways in the liver, including epigenetic changes. Additionally, hepatic cytokine and FFA levels of cytokines are induced as a result of the associated multiple organ damages, such as those in the adipose tissue, brain, intestines, and muscles. Eventually, this pathway increases hepatic inflammation and hepatocyte lipotoxicity, which result in the stimulation of ASH.

References

    1. Abenavoli L., Masarone M., Federico A., Rosato V., Dallio M., Loguercio C., et al. (2016). Alcoholic hepatitis: pathogenesis, diagnosis and treatment. Rev. Recent Clin. Trials 11 159–166. 10.2174/1574887111666160724183409 - DOI - PubMed
    1. Anest V., Hanson J. L., Cogswell P. C., Steinbrecher K. A., Strahl B. D., Baldwin A. S. (2003). A nucleosomal function for ikappab kinase-alpha in nf-kappab-dependent gene expression. Nature 423 659–663. 10.1038/nature01648 - DOI - PubMed
    1. Anstee Q. M., Seth D., Day C. P. (2016). Genetic factors that affect risk of alcoholic and nonalcoholic fatty liver disease. Gastroenterology 150 1728.e–1744.e. 10.1053/j.gastro.2016.01.037 - DOI - PubMed
    1. Argentieri M. A., Nagarajan S., Seddighzadeh B., Baccarelli A. A., Shields A. E. (2017). Epigenetic pathways in human disease: the impact of DNA methylation on stress-related pathogenesis and current challenges in biomarker development. EBioMedicine 18 327–350. 10.1016/j.ebiom.2017.03.044 - DOI - PMC - PubMed
    1. Aroor A. R., James T. T., Jackson D. E., Shukla S. D. (2010). Differential changes in map kinases, histone modifications, and liver injury in rats acutely treated with ethanol. Alcohol Clin. Exp. Res. 34 1543–1551. 10.1111/j.1530-0277.2010.01239.x - DOI - PMC - PubMed